Profile
ACER VRTX REGN SGEN ALNY ARGX
Company Name Acer Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap - $130.72B $58.75B $43.15B $35.25B $34.28B
Employees 0.03K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Mr. Christopher Schelling Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACER VRTX REGN SGEN ALNY ARGX
Quant Rating Score 3 2 4 3 1 3
Quant Rating Neutral Sell Buy Neutral Strong Sell Neutral
Trading
ACER VRTX REGN SGEN ALNY ARGX
Last Close $0.6601 $485.89 $549.28 $228.74 $230.5 $587.59
High 52 $0.9 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $0.66 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High -26.66 % -5.97 % -54.29 % 0 % -22.33 % -12.53 %
Price vs. 52 Week Low 0.02 % 23.7 % 0.53 % 0 % 60.84 % 65.05 %
Total Return
ACER VRTX REGN SGEN ALNY ARGX
1 Month Return 0 % -5.42 % -18.95 % 0 % -8.97 % -4.33 %
3 Month Return 0 % 15.14 % -19.41 % 0 % -6.4 % -8.26 %
6 Month Return -26.66 % -2.58 % -44.96 % 0 % -22.31 % 8.15 %
9 Month Return 0 % -0.51 % -49.4 % 0 % -3.97 % 26.8 %
YTD Return 0 % 20.66 % -22.89 % 0 % -2.04 % -4.46 %
1 Year Return 0 % 23.6 % -39.05 % 0 % 58.62 % 60.46 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACER VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.16 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Profitability
ACER VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 77.46 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -162.99 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM 56.36 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM 36.02 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 132.9 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -4618.85 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM -118.44 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM - 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM 0.01 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM 0.02 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 907.34 % 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 2.66 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -0.88 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -0.88 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 2.43 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -5782.67 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM -118.44 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM - -165.4 16.33 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -0.75 -266.09 13.37 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -0.75 -266.09 13.37 -203.89 -4192.79 -531.16
Income Statement (TTM)
ACER VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.03B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1.77 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ACER VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.01B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.03B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $-0.02B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
ACER VRTX REGN SGEN ALNY ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 18.66
ABCL AbCellera Biologics Inc. 2.415
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.8871
ABPWW 0.0465
ABSI Absci Corporation 3.05
ABUS Arbutus Biopharma Corporation 3.015
ABVC ABVC BioPharma, Inc. 0.86
ABVX Abivax SA American Depositary Shares 6.26
ACAD ACADIA Pharmaceuticals Inc. 14.64
ACET Adicet Bio, Inc. 0.5655
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.02
ACIU AC Immune SA 1.5
ACLX Arcellx, Inc. 60.99
ACRV Acrivon Therapeutics, Inc. Common Stock 1.755
ETFs With Exposure to ACER
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 260.14
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 115.463
IWC iShares Micro-Cap ETF 0.0034 104.585
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.03 33.28
Unlock